Abvc biopharma, inc. ceo selected as 2024 top 10 ceo in ceo insights asia magazine

Fremont, ca, march 19, 2024 (globe newswire) -- via newmediawire --  abvc biopharma, inc.  (nasdaq: abvc) ("company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, cns, and ophthalmology, proudly announced today that its ceo, dr. uttam patil, was selected as one of the top 10 ceos in taiwan 2024 by  ceo insights asia magazine . this recognition is a testament to dr. patil's outstanding leadership, innovative vision, and significant contributions to the company. dr. patil is confident in the company's prospects, so he owns stock options without claiming a salary. within his first year as the company's ceo, the company saw a rise in the stock price of its common stock, an increase in its social media presence, and a renewed focus on its essential products.
ABVC Ratings Summary
ABVC Quant Ranking